Multiomic Health Revenue and Competitors

London, London

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Multiomic Health's estimated annual revenue is currently $1.8M per year.(i)
  • Multiomic Health's estimated revenue per employee is $77,500

Employee Data

  • Multiomic Health has 23 Employees.(i)
  • Multiomic Health grew their employee count by 35% last year.

Multiomic Health's People

NameTitleEmail/Phone
1
Co-Founder & CEOReveal Email/Phone
2
Chief Technology & Data OfficerReveal Email/Phone
3
Chief Science and IP OfficerReveal Email/Phone
4
Chief StaffReveal Email/Phone
5
VP, Study & Partnership OpsReveal Email/Phone
6
Head Disease BiologyReveal Email/Phone
7
BioinformaticianReveal Email/Phone
8
Lead Data ScientistReveal Email/Phone
9
Partnerships & Operations AssociateReveal Email/Phone
10
Science and Business AnalystReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$1.2M1623%N/AN/A
#2
$11.8M7621%N/AN/A
#3
$1.8M2335%N/AN/A
#4
$2.2M2961%N/AN/A
#5
$1.8M2335%N/AN/A
#6
$0.9M129%N/AN/A
#7
$0.1M10%N/AN/A
#8
$18.3M118-3%N/AN/A
#9
$0.5M620%N/AN/A
#10
$4.8M6241%N/AN/A
Add Company

What Is Multiomic Health?

Multiomic Health is a data-centric therapeutics venture, writing the latest chapter of the precision medicine story by tackling a global, trillion dollar healthcare problem: metabolic syndrome-related conditions (atherosclerotic cardiovascular disease, type 2 diabetes, chronic kidney disease and non-alcoholic fatty liver). \n\nOur mission is to transform patient health outcomes with precision medicines that go beyond the one-size-fits-all approach currently dominating this disease space. We apply advanced computational systems biology modelling and AI-enabled predictive analytics on deep, standardised patient datasets. These datasets feed into a data lake of thousands of patients, featuring millions of data points per patient accumulated from a wide spectrum of omics, rich clinical phenotyping and various tissue types collected over multiple time points. We use our proprietary MOHSAIC® platform to identify unique patient endotypes, re-position existing drug candidates and discover novel drug targets, leading to breakthrough precision therapeutics for the world’s largest patient population.

keywords:N/A

N/A

Total Funding

23

Number of Employees

$1.8M

Revenue (est)

35%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$2.3M235%N/A
#2
$3.5M23-18%N/A
#3
$1.6M23-38%$4.9M
#4
$3.3M23-57%N/A
#5
$1.6M23-12%N/A